Cochrane Abstracts
Genetic testing for prevention of severe drug‐induced skin rash
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Genetic Testing for Prevention of Severe Drug‐induced Skin Rash." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437578/all/Genetic_testing_for_prevention_of_severe_drug‐induced_skin_rash.
Genetic testing for prevention of severe drug‐induced skin rash. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437578/all/Genetic_testing_for_prevention_of_severe_drug‐induced_skin_rash. Accessed January 22, 2025.
Genetic testing for prevention of severe drug‐induced skin rash. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437578/all/Genetic_testing_for_prevention_of_severe_drug‐induced_skin_rash
Genetic Testing for Prevention of Severe Drug‐induced Skin Rash [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437578/all/Genetic_testing_for_prevention_of_severe_drug‐induced_skin_rash.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Genetic testing for prevention of severe drug‐induced skin rash
ID - 437578
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437578/all/Genetic_testing_for_prevention_of_severe_drug‐induced_skin_rash
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
